Bilcare can test Rs 650-660: Chouhan

Excerpts from Markets Midday on CNBC-TV18 Watch the full show » RELATED NEWS Buy Bilcare, says Ranjit Kapadia ALSO READ See previous views by Shrikant Chouhan See what other Experts & Brokerages are saying about Bilcare See messages about Bilcare BSE | NSE 01/01/70 Are Mutual Funds betting on ?

Bilcare can test Rs 650-660, says Shrikant Chouhan , Kotak Securities.

Chouhan told CNBC-TV18, "In pharmaceutical space, Bilcare is looking good. The liquidity is drying out. We can expect Rs 650-660 if we keep a view of at least three-four months from here."

The share closed at Rs 559.00, up Rs 13.80, or 2.53% with volumes of 28,308 shares. Yesterday the share closed down 0.16% or Rs 0.85 at Rs 545.20.

The company touched its 52 week high Rs 589.90 and 52 week low Rs 310.05 on 08 Mar, 2010 and 27 Mar, 2009, respectively. Currently, it is trading -5.24% below its 52-week high and 80.29% above its 52-week low. Market capitalisation stands at Rs 961.93 crore.

Disclosure: I do not have a personal holding in the above stock/sector but may have recommended them to clients.